CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year later in Europe for treating acute lymphoblastic leukemia (ALL).
from News Medical Medical Research News Feed https://ift.tt/IkhEw1Q
0 Comments